Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load <500 copies/ml at delivery: a case-control study nested in the French perinatal cohort (EPF-ANRS CO1).
about
Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxisThe 2015 Clinical Guidelines for the Diagnosis and Treatment of HIV/AIDS in HIV-Infected KoreansPreconception and contraceptive care for women living with HIVCare of the HIV-infected pregnant woman in the developed worldWhat will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysisInitiation of antiretroviral therapy.Contribution of different antiretroviral regimens containing zidovudine, lamivudine and ritonavir-boosted lopinavir on HIV viral load reduction during pregnancy.Evolution of HIV treatment guidelines in high- and low-income countries: converging recommendationsProtecting the fetus against HIV infection: a systematic review of placental transfer of antiretrovirals.Low rates of mother-to-child HIV transmission in a routine programmatic setting in Lilongwe, Malawi.Antiretroviral treatment in HIV-1 infected pediatric patients: focus on efavirenz.No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception.The breadth and titer of maternal HIV-1-specific heterologous neutralizing antibodies are not associated with a lower rate of mother-to-child transmission of HIV-1Estimates of peripartum and postnatal mother-to-child transmission probabilities of HIV for use in Spectrum and other population-based models.Socio-economic, clinical and biological risk factors for mother - to - child transmission of HIV-1 in Muhima health centre (Rwanda): a prospective cohort study.Pregnancy rate and birth outcomes among women receiving antiretroviral therapy in Burkina Faso: a retrospective cohort study.Antiretrovirals and safer conception for HIV-serodiscordant couplesComparative effectiveness of congregation- versus clinic-based approach to prevention of mother-to-child HIV transmission: study protocol for a cluster randomized controlled trialAntiretroviral treatment, viral load of mothers & perinatal HIV transmission in Mumbai, India.Short communication: Use of raltegravir in late-presenting HIV-infected pregnant women.Linkage to Care, Early Infant Diagnosis, and Perinatal Transmission Among Infants Born to HIV-Infected Nigerian Mothers: Evidence From the Healthy Beginning Initiative.The case for addressing primary resistance mutations to non-nucleoside reverse transcriptase inhibitors to treat children born from mothers living with HIV in sub-Saharan Africa.Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish recommendations 2013.Tolerance of the newborn to antiretroviral drug exposure in utero.Treatment change in pregnancy is a significant risk factor for detectable HIV-1 RNA in plasma at end of pregnancy.Efavirenz-based antiretroviral therapy versus nevirapine-including regimens for prevention of mother-to-child transmission of HIV option B plus in resource-limited settings: is there anything missing?Pregnancy outcomes in perinatally HIV-infected young women in Madrid, Spain: 2000-2015.The cascade of care to prevent mother-to-child transmission in Rio de Janeiro, Brazil, 1996-2013: improving but still some way to go.Increasing heterosexual transmission of HIV-1 subtype C in Inland Central Western Brazil.Incident and long-term HIV-1 infection among pregnant women in Brazil: Transmitted drug resistance and mother-to-child transmission.Child desire in women and men living with HIV attending HIV outpatient clinics: evidence from a European multicentre study.Pregnant and breastfeeding women: A priority population for HIV viral load monitoring.Long-term administration of tenofovir or emtricitabine to pregnant rats; effect on Abcb1a, Abcb1b and Abcg2 expression in the placenta and in maternal and fetal organs.Economic evaluation of universal prenatal HIV screening compared with current 'at risk' policy in a very low prevalence country.A clinical approach to elimination of perinatal HIV transmission in resource-rich settings.Genetic relatedness of human immunodeficiency virus-1 (HIV-1) strains in a 12-year-old daughter and her father in a household setting.Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011.Factors associated with time to achieve an undetectable HIV RNA viral load after start of antiretroviral treatment in HIV-1-infected pregnant women.Transmitted HIV resistance among pregnant young women infected with HIV-1 in Brazil.Is it a rights violation or lack of knowledge about options? An examination of HIV counselors views on whether women infected with HIV should procreate.
P2860
Q22242951-79FF5703-927D-4927-ADD7-586519ED4EDCQ26781379-86C44D09-FC4F-4F2A-A8AE-0EFF5BD82E78Q27012918-819E7409-0FCE-47C5-AA1C-177EF11E16AFQ28082774-1A1E4AAB-C12A-49CE-868B-A6A84E9DC716Q28478769-EF60DB72-3FDD-461F-AC3A-28D072C8E52BQ30209635-6F616CF8-9383-4F6F-85D6-7E03C0C42014Q33714594-6110B687-BA32-4EEF-A889-9B8F73E1EFF9Q34321843-8830D9D6-6254-40CB-B995-7B93B77EFB43Q34429204-F2196823-9661-4F70-B123-BA058C523BD2Q34761065-5C320735-E0FF-4CB5-BF4A-9B5A3F7C469CQ35547048-7CEE3665-EFFC-4E8A-97F9-A61391F7AD35Q35703796-DCF57D26-2A66-4AE1-A368-94897AA2B325Q36276632-2AE4B4FF-4FD9-431C-BE86-195D13371A60Q36440580-F125A4F3-08FE-4C28-A949-CBB4EBA2FE69Q36688427-E47DB6A0-EDDC-46AD-A91B-28ABFD91980DQ36901751-82923F64-0CCE-4633-A255-3523395545F4Q36964167-59FE7AF1-2D65-4314-85FB-F3AE64D6B143Q36980724-063E5E9F-6652-444B-A6CC-227FFC4F98F3Q37210260-FE4ACE20-3B31-46D0-89B3-82990053350DQ37259753-7D7C7D75-DB73-42DE-9774-9533F130ECD0Q37420071-888CB7C5-F6F1-45DE-A8A8-439F3DCCEA80Q37491651-16DDD042-37D5-4E25-A2B5-5E0B3B411000Q38206255-6FBF711C-1C04-4E64-A201-5C2B15201C3BQ38366365-1671DD2F-752A-40A3-90A0-E96A80060EFEQ38440876-389F9757-D24E-483D-B52B-F8855A3FD552Q38630880-72EE074E-51DA-4A6C-93F2-063127209CF9Q38637240-02337E0C-2E6E-4A70-A191-C275D736BFECQ38679607-888EE5F3-F8A7-4989-B89E-581206174227Q38867834-09F073BF-9F5F-4F35-A552-CE41AAD5768FQ39180480-638354ED-44B1-4AC8-855C-3B51585BBFE6Q39313531-A3D79242-3209-4075-ADFC-5F0B007A329DQ40082574-15203D74-D87D-4C9F-856A-AC3E3989FF46Q40148984-06FC67F5-58AD-4892-ADAB-67FC87AFBA99Q40327623-1AC2593D-1772-4E6F-853D-E84340C626B5Q40994072-F5AF5E15-29EB-4EB0-B898-F1BD514135FEQ42234436-44DEFD7B-8038-44A8-A998-1C611861BD74Q42260917-F5B23D93-2B07-4021-BC64-2A9C76A01795Q42318291-9C9A6ECA-6271-48A3-AE11-915FCF52FA68Q42549313-7868336A-93FD-4DE3-A985-259902AF1BE9Q43179512-0E2C7193-E71E-4536-AC32-BB2DB2817748
P2860
Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load <500 copies/ml at delivery: a case-control study nested in the French perinatal cohort (EPF-ANRS CO1).
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Factors associated with mother ...... rinatal cohort (EPF-ANRS CO1).
@en
Factors associated with mother ...... in the French perinatal cohort
@nl
type
label
Factors associated with mother ...... rinatal cohort (EPF-ANRS CO1).
@en
Factors associated with mother ...... in the French perinatal cohort
@nl
prefLabel
Factors associated with mother ...... rinatal cohort (EPF-ANRS CO1).
@en
Factors associated with mother ...... in the French perinatal cohort
@nl
P2093
P356
P1476
Factors associated with mother ...... rinatal cohort (EPF-ANRS CO1).
@en
P2093
Albert Faye
Catherine Dollfus
Constance Delaugerre
Jerome Le Chenadec
Josiane Warszawski
Karima Hamrene
Laurent Mandelbrot
Roland Tubiana
Stephane Blanche
P304
P356
10.1086/650005
P407
P577
2010-02-01T00:00:00Z